Medicine

Faysal Alghoula, a pulmonologist from Libya who treats patients in an underserved area, outside of Deaconess Gateway Hospital in Newburgh, Indiana, March 31, 2026.

International

Trump’s immigration policy sidelines foreign doctors amid shortage

American medical schools do not produce enough doctors as it is

AstraZeneca has made major moves to grow in the US, with a US$50 billion US manufacturing deal in 2025, and a New York Stock Exchange listing this year.

Consumer & Healthcare

AstraZeneca forecasts growth in 2026 as it builds drug pipeline

Its chief executive officer Pascal Soriot has a target of US$80 billion in annual sales by 2030

When universities, hospitals and companies work together, innovation bears fruit earlier because real clinical problems guide the design of new solutions.

Opinion & Features

THE BROAD VIEW

Why healthcare innovation must be a team sport

The future of healthcare will be built by ecosystems that learn, fail, adapt and scale – together

The deals include agreements with Eli Lilly and Novo Nordisk to slash the prices of popular GLP-1 weight-loss drugs.

International

Trump unveils TrumpRx discounted drugs website

The website is targeted at consumers looking to buy drugs without using insurance

Haw Par's revenue for H1 rose 7 per cent to S$126.3 million, from S$118.1 million a year earlier, as demand for healthcare products remained resilient.

Companies & Markets

Haw Par Corporation H1 net profit up 18.2% at S$144.1 million

It declares an interim dividend of 20 Singapore cents per share, unchanged from the year before

White House Press Secretary Karoline Leavitt holds US President Donald Trump's letter to Eli Lilly CEO David Ricks during a press briefing at the White House in Washington, D.C., July 31, 2025.

International

Trump pressures 17 pharma CEOs to cut US drug prices

[WASHINGTON] President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash US prescription drug prices to match those paid overseas, the White...

Its traditional Chinese medicine formula, which forms the basis of its product candidates, “contains only natural ingredients without any synthetic components”.

Companies & Markets

Herbal medicine stock with no sales rallies 64,000%

The unbelievable rally has transformed Regencell Bioscience Holdings Limited, a penny stock as recently as April, to one worth more than US$20 billion in market value

YMS’s philosophy is that just as employees contribute to the business, the company must also value-add to their careers.

Singapore

ENTERPRISE 50

Providing caregivers with more than just homecare products

Yeap Medical Supplies wants to be an advocate for caregivers too

Singapore’s strengths position it to ride the precision-medicine wave. The country has deep research and development and clinical expertise, strengths in genomics, and a burgeoning biomedical industry.

Opinion & Features

Singapore has a chance to shine in precision medicine

Existing research capabilities and support for new startups can drive growth in this field

Oxford Nanopore CEO Gordon Sanghera says science breakthroughs can be turned into real-world applications, in areas such as diagnostics and healthcare.

Consumer & Healthcare

Temasek-backed biotech Oxford Nanopore wants to make genetics tech accessible to startups

The London-listed company is working with Singapore to catalogue 10,000 genes, which can help to pinpoint how genetic factors influence responses to medication

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News